Lynch syndrome–associated colorectal cancers in MLH1 mutation carriers are driven by somatic mutations in Wnt signaling pathway genes. This study reveals that these mutations are heterogeneous across tumors, highlighting Wnt pathway dysregulation as a central but diverse oncogenic mechanism in MLH1-deficient hereditary colorectal cancer.

Some colorectal cancers carry a DNA repair defect — called mismatch repair — making them unusually responsive to immunotherapy. Studying all such tumors in a large Finnish population over 15 years, researchers found that despite a favorable immune environment, most patients with metastatic disease were too elderly or frail to receive treatment, and many tumors showed features likely to limit immunotherapy benefit. The findings reveal a significant gap between these cancers’ theoretical treatability and what is achievable in real-world care.

Certain cancers of the digestive system — including colorectal, stomach, and pancreatic cancers — can run in families due to inherited changes in specific genes. This comprehensive review describes the most important of these hereditary conditions, how they are recognized, and what they mean for affected individuals and their relatives. People who carry these genetic changes may face substantially higher lifetime cancer risks, but early identification opens the door to tailored screening, preventive surgery, and testing of family members who may also be at risk. Managing these syndromes well requires coordinated care from specialists across multiple disciplines, ideally in centers with dedicated expertise in hereditary cancer.